14 Nov Plaque Psoriasis Market Size, Industry Share, Trends 2024-34
Market Overview:
The plaque psoriasis market is expected to exhibit a CAGR of 8.93% during 2024-2034. The plaque psoriasis market report offers a comprehensive analysis of the market in the United States, EU5 (including Germany, Spain, Italy, France, and the United Kingdom), and Japan. It covers aspects such as treatment methods, drugs available in the market, drugs in development, the market share of various therapies, and the market’s performance in the seven major regions. Additionally, the report evaluates the performance of leading companies and their pharmaceutical products. Current and projected patient numbers across these key markets are also detailed in the report. This study is essential for manufacturers, investors, business planners, researchers, consultants, and anyone interested or involved in the plaque psoriasis market.
Request for a Sample of this Report: https://www.imarcgroup.com/plaque-psoriasis-market/requestsample
Plaque Psoriasis Market Trends:
Plaque psoriasis refers to a chronic autoimmune illness defined by the formation of raised, red, and scaly skin patches known as plaques. The plaque psoriasis market is experiencing substantial growth, primarily driven by the increasing prevalence of the disease. This rising incidence is prompting greater demand for effective and long-lasting treatment options. Moreover, the market is benefiting from the continuous advancements in biologic therapies, including tumor necrosis factor (TNF) inhibitors, interleukin inhibitors, and monoclonal antibodies, which offer targeted medication with minimal side effects compared to traditional systemic therapies. Additionally, the growing awareness about psoriasis among healthcare professionals and patients is leading to earlier diagnosis and timely initiation of therapy, further driving the expansion of the plaque psoriasis market.
In line with these factors, pharmaceutical companies are investing heavily in research and development, leading to the introduction of novel therapies, such as oral small molecules and biosimilars, which aim to provide cost-effective alternatives while maintaining efficacy. Furthermore, the expansion of healthcare infrastructure, especially in emerging markets, is improving access to advanced psoriasis treatments. The rising adoption of digital health solutions, such as telemedicine and mobile health apps, is enhancing patient management and compliance by providing convenient access to healthcare services. Consequently, the trend toward personalized medicine, focusing on treatments tailored to individual genetic and immunologic profiles, is anticipated to drive the growth of the plaque psoriasis market in the coming years, offering more precise and effective care options.
Countries Covered:
- United States
- Germany
- France
- United Kingdom
- Italy
- Spain
- Japan
Analysis Covered Across Each Country:
- Historical, current, and future epidemiology scenario
- Historical, current, and future performance of the plaque psoriasis market
- Historical, current, and future performance of various therapeutic categories in the market
- Sales of various drugs across the plaque psoriasis market
- Reimbursement scenario in the market
- In-market and pipeline drugs
This report also provides a detailed analysis of the current plaque psoriasis market and late-stage pipeline drugs.
In-Market Drugs:
- Drug Overview
- Mechanism of Action
- Regulatory Status
- Clinical Trial Results
- Drug Uptake and Market Performance
Late-Stage Pipeline Drugs:
- Drug overview
- Mechanism of action
- Regulatory status
- Clinical trial results
- Drug uptake and market performance
Competitive Landscape With Key Players:
The competitive landscape of the plaque psoriasis market has been studied in the report with the detailed profiles of the key players operating in the market.
Some of these Key Players:
- Ortho Dermatologics
- AstraZeneca
- Sun Pharmaceutical Industries
- Arcutis Biotherapeutics
- Pfizer
- Affibody
- Akeso Biopharma
- Alumis Inc
- Hangzhou Highlightll Pharmaceutical
- Janssen Biotech
Ask Analyst for Customization and Explore Full Report With TOC & List of Figures: https://www.imarcgroup.com/request?type=report&id=7500&flag=C
If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
About Us:
IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.
Contact Us:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
United States: +1-631-791-1145
Sin comentarios